Cargando…
Solution structures and biophysical analysis of full-length group A PAKs reveal they are monomeric and auto-inhibited in cis
The group A p21-activated kinases (PAKs) exist in an auto-inhibited form until activated by GTPase binding and auto-phosphorylation. In the auto-inhibited form, a regulatory domain binds to the kinase domain (KD) blocking the binding of substrates, and CDC42 or Rac binding to the regulatory domain r...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6448136/ https://www.ncbi.nlm.nih.gov/pubmed/30858169 http://dx.doi.org/10.1042/BCJ20180867 |
_version_ | 1783408640347078656 |
---|---|
author | Sorrell, Fiona J. Kilian, Lena Marie Elkins, Jonathan M. |
author_facet | Sorrell, Fiona J. Kilian, Lena Marie Elkins, Jonathan M. |
author_sort | Sorrell, Fiona J. |
collection | PubMed |
description | The group A p21-activated kinases (PAKs) exist in an auto-inhibited form until activated by GTPase binding and auto-phosphorylation. In the auto-inhibited form, a regulatory domain binds to the kinase domain (KD) blocking the binding of substrates, and CDC42 or Rac binding to the regulatory domain relieves this auto-inhibition allowing auto-phosphorylation on the KD activation loop. We have determined the crystal structure of the PAK3 catalytic domain and by small angle X-ray scattering, the solution-phase structures of full-length inactive PAK1 and PAK3. The structures reveal a compact but elongated molecular shape that demonstrates that, together with multiple independent biophysical measurements and in contrast with previous assumptions, group A PAKs are monomeric both before and after activation, consistent with an activation mechanism of cis-auto-inhibition and initial cis-auto-phosphorylation, followed by transient dimerisation to allow trans-auto-phosphorylation for full activation, yielding a monomeric active PAK protein. |
format | Online Article Text |
id | pubmed-6448136 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Portland Press Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-64481362019-04-16 Solution structures and biophysical analysis of full-length group A PAKs reveal they are monomeric and auto-inhibited in cis Sorrell, Fiona J. Kilian, Lena Marie Elkins, Jonathan M. Biochem J Research Articles The group A p21-activated kinases (PAKs) exist in an auto-inhibited form until activated by GTPase binding and auto-phosphorylation. In the auto-inhibited form, a regulatory domain binds to the kinase domain (KD) blocking the binding of substrates, and CDC42 or Rac binding to the regulatory domain relieves this auto-inhibition allowing auto-phosphorylation on the KD activation loop. We have determined the crystal structure of the PAK3 catalytic domain and by small angle X-ray scattering, the solution-phase structures of full-length inactive PAK1 and PAK3. The structures reveal a compact but elongated molecular shape that demonstrates that, together with multiple independent biophysical measurements and in contrast with previous assumptions, group A PAKs are monomeric both before and after activation, consistent with an activation mechanism of cis-auto-inhibition and initial cis-auto-phosphorylation, followed by transient dimerisation to allow trans-auto-phosphorylation for full activation, yielding a monomeric active PAK protein. Portland Press Ltd. 2019-04-15 2019-04-04 /pmc/articles/PMC6448136/ /pubmed/30858169 http://dx.doi.org/10.1042/BCJ20180867 Text en © 2019 The Author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY) (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Research Articles Sorrell, Fiona J. Kilian, Lena Marie Elkins, Jonathan M. Solution structures and biophysical analysis of full-length group A PAKs reveal they are monomeric and auto-inhibited in cis |
title | Solution structures and biophysical analysis of full-length group A PAKs reveal they are monomeric and auto-inhibited in cis |
title_full | Solution structures and biophysical analysis of full-length group A PAKs reveal they are monomeric and auto-inhibited in cis |
title_fullStr | Solution structures and biophysical analysis of full-length group A PAKs reveal they are monomeric and auto-inhibited in cis |
title_full_unstemmed | Solution structures and biophysical analysis of full-length group A PAKs reveal they are monomeric and auto-inhibited in cis |
title_short | Solution structures and biophysical analysis of full-length group A PAKs reveal they are monomeric and auto-inhibited in cis |
title_sort | solution structures and biophysical analysis of full-length group a paks reveal they are monomeric and auto-inhibited in cis |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6448136/ https://www.ncbi.nlm.nih.gov/pubmed/30858169 http://dx.doi.org/10.1042/BCJ20180867 |
work_keys_str_mv | AT sorrellfionaj solutionstructuresandbiophysicalanalysisoffulllengthgroupapaksrevealtheyaremonomericandautoinhibitedincis AT kilianlenamarie solutionstructuresandbiophysicalanalysisoffulllengthgroupapaksrevealtheyaremonomericandautoinhibitedincis AT elkinsjonathanm solutionstructuresandbiophysicalanalysisoffulllengthgroupapaksrevealtheyaremonomericandautoinhibitedincis |